Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for Daiichi Sankyo 17 found (333 total)

alternate case: daiichi Sankyo

Laninamivir (323 words) [view diff] exact match in snippet view article find links to article

is currently marketed under the name Inavir by Daiichi Sankyo. Biota Pharmaceuticals and Daiichi Sankyo co-own Laninamivir. On 1 April 2011, BARDA awarded
Tivantinib (252 words) [view diff] exact match in snippet view article find links to article
Österreichische Apothekerzeitung (in German) (24/2014): 30. "ArQule, Daiichi Sankyo Say Cancer Candidate Tivantinib Fails Phase III Trial". Genetic Engineering
Randeep Guleria (704 words) [view diff] exact match in snippet view article find links to article
2020. "Sehat". Sehat. 2015. Retrieved 21 February 2015. "Daiichi Sankyo India". Daiichi Sankyo India. 2015. Retrieved 21 February 2015. "SAGE". SAGE. 2015
Pefloxacin (368 words) [view diff] exact match in snippet view article find links to article
779,600. Generics (UK) Limited v. Daiichi Pharmaceutical Co. Ltd & Daiichi Sankyo Co. Ltd, 2016-07-13 (EWHC 15 October 2008), Text. "Reasons for prescribing
Religare (1,020 words) [view diff] exact match in snippet view article find links to article
were part of Ranbaxy Group before selling their stake in Ranbaxy to Daiichi Sankyo in 2008. In 2000, it secured membership of the Futures and Options segment
Quizartinib (1,251 words) [view diff] exact match in snippet view article find links to article
that is FLT3-ITD positive. The applicant for this medicinal product is Daiichi Sankyo Europe GmbH. Quizartinib was approved for medical use in Japan in October
Radius Ventures (511 words) [view diff] exact match in snippet view article find links to article
Market-Leading Autonomous Mobile Robot Technology". July 17, 2017. "Daiichi Sankyo to Acquiere Ambit Biosciences". September 29, 2014. "FAQs On The Proposed
List of medical museums (382 words) [view diff] exact match in snippet view article find links to article
Padova Chieti Museum of Biomedical Sciences Cannabis Museum (Japan) Daiichi Sankyo Kusuri Museum Medical Museum of Kawasaki Medical School Medical Science
Perfluoro tert-butylcyclohexane (903 words) [view diff] exact match in snippet view article find links to article
"Ultrasound Contrast Agent Sonazoid® for Injection Released for Sale" (PDF). Daiichi Sankyo Company, Ltd. January 10, 2007. Mahon RT, Cronin WA, Bodo M, Tirumala
International Federation of Pharmaceutical Manufacturers & Associations (557 words) [view diff] exact match in snippet view article find links to article
Association Les entreprises du médicament France CEOs from Pfizer, Roche, and Daiichi Sankyo take up roles on IFPMA CEO leadership team,IFPMA,12 July 2023, [1] "International
Mone Kamishiraishi (3,876 words) [view diff] exact match in snippet view article find links to article
Kamiki (2019) Suntory Foods "Iyemon" Tokucha (Special Tea Life) (2019) Daiichi Sankyo Health Care Minon Amino Moist (2019) Lottery "Dreaming Lottery" (2019)
Natsuna Watanabe (1,689 words) [view diff] exact match in snippet view article find links to article
spokesperson (2013) Unicharm – Sofy (2012) Choya Umeshu – Umesshu (2012) Daiichi Sankyo Healthcare – Kakonāru 2 (2012) Aigan (2013) Tsukamoto – Kimono Journal
Izumi Yamaguchi (310 words) [view diff] exact match in snippet view article find links to article
Company Product Daiichi Sankyo Healthcare Lulu Oenon Holdings Tomihisa Musume Seven Two Seven Cosmetics 727 SoftBank Mobile
Sanford Burnham Prebys Medical Discovery Institute (2,507 words) [view diff] no match in snippet view article find links to article
out to the public. Recent agreements include partners such as Lilly, Daiichi-Sankyo, and Boehringer Ingelheim. "Burnham Awarded $97.9 Million NIH Grant
Gabapentinoid (4,035 words) [view diff] exact match in snippet view article find links to article
(in Russian). 2017 (24): 1657–1663. ISSN 1382-4368. "Mirogabalin - Daiichi Sankyo Company - AdisInsight". Chan A, Yuen A, Tsai D (2023). "Gabapentinoid
Discovery and development of neuraminidase inhibitors (4,066 words) [view diff] exact match in snippet view article find links to article
approved in Japan and is commercially available under the name of Inavir (Daiichi Sankyo Company Ltd. Neuraminidase Neuraminidase inhibitors Influenza virus
Adenosine diphosphate receptor inhibitor (5,282 words) [view diff] exact match in snippet view article find links to article
was brought to the market in 2009 by the pharmaceutical companies, Daiichi Sankyo/Eli Lilly. Prasugrel, like its precursors is a pro-drug but its metabolism